Product NDC: | 0069-4395 |
Proprietary Name: | Ciprofloxacin |
Non Proprietary Name: | Ciprofloxacin |
Active Ingredient(s): | 2 mg/mL & nbsp; Ciprofloxacin |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-4395 |
Labeler Name: | Pfizer Labs, Division of Pfizer Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078024 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090911 |
Package NDC: | 0069-4395-19 |
Package Description: | 100 mL in 1 BAG (0069-4395-19) |
NDC Code | 0069-4395-19 |
Proprietary Name | Ciprofloxacin |
Package Description | 100 mL in 1 BAG (0069-4395-19) |
Product NDC | 0069-4395 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ciprofloxacin |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20090911 |
Marketing Category Name | ANDA |
Labeler Name | Pfizer Labs, Division of Pfizer Inc |
Substance Name | CIPROFLOXACIN |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |